Drug Type Small molecule drug |
Synonyms- |
Target |
Action inhibitors |
Mechanism ATF4 inhibitors(activating transcription factor 4 inhibitors), CHOP inhibitors(DNA damage inducible transcript 3 inhibitors), PERK inhibitors(eukaryotic translation initiation factor 2 alpha kinase 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Colitis, Ulcerative | Preclinical | China | 27 Mar 2025 |





